About 20n Bio
20n Bio is a VC-backed start-up dedicated to designing and screening cyclic peptides for therapeutics.
Sectors & Market Categories
Company Details
Corporate & Operational Profile
Primary Industry
Biotech & Healthcare
Funding Stage
Seed
Global Headquarters
Philadelphia, United States
Tracked Since
Oct 2, 2026
Web & Domain Identity
Official Website
20n.bio
Domain Registered Date
May 26, 2021
Social & Network Presence
LinkedIn Corporate
Not linked
Company Milestones & Timeline
- Capital Raise
Seed announced
startupintros.com
- Milestone
X account created (@20nBio)
4 followers
- Capital Raise
Raised $3,300,000 · Seed
startupintros.com
- Milestone
Website domain registered
20n.bio
Investors & Backers
Investor firms and individual backers were not publicly disclosed in available round filings for 20n Bio.
Funding History
Seed
· May 20, 2026
Undisclosed startupintros.com
Seed
· Dec 20, 2021
$3,300,000 startupintros.com
Founders & Leadership
Mingfu Zhu
Founder
Work email & phone locked
Unlock →
Press Coverage & Sources
Recently Funded Biotech & Healthcare Startups
View allVitalls
vitalls.ai
Seed Abu Dhabi, United Arab Emirates · Oct 2026
Hexagon Bio
hexagonbio.com
Series-B+ Oct 2026
RefloDx
reflodx.com
Seed Kaysville, United States · Oct 2026
HeyVoli
heyvoli.com
Pre-Seed Bangalore, India · Oct 2026
CureBay
curebay.com
Series-B+ Bhubaneshwar, India · Oct 2026
4Tissue
4tissue.com
Series-A Ghent, Belgium · Oct 2026